Refine
Has Fulltext
- yes (69)
Is part of the Bibliography
- yes (69)
Year of publication
- 2019 (69) (remove)
Document Type
- Doctoral Thesis (69) (remove)
Keywords
- Maus (4)
- Tissue Engineering (4)
- Genetik (3)
- Genexpression (3)
- Megakaryozyt (3)
- ADHD (2)
- Alzheimerkrankheit (2)
- Angst (2)
- Aufmerksamkeit (2)
- Blutgerinnung (2)
- Elektrophysiologie (2)
- Fluoreszenzmikroskopie (2)
- Lungenkrebs (2)
- Mitose (2)
- Neisseria meningitidis (2)
- Phosphoglykolatphosphatase (2)
- Serotonin (2)
- Thrombozyt (2)
- Tiermodell (2)
- Verhalten (2)
- megakaryopoiesis (2)
- (hem)ITAM signaling (1)
- 3D Modell (1)
- 3D Tumormodell (1)
- 3D model (1)
- 3D tissue model (1)
- 3D-Elektrode (1)
- 3D-Modell (1)
- 4-HNE (1)
- ADHS (1)
- AMP‐activated protein kinase (1)
- APOBEC3G (1)
- Absorbed Doses (1)
- Actin (1)
- Actin-bindende Proteine (1)
- Adaptation (1)
- Adhesion GPCR (1)
- Adipositas (1)
- Administered Activities (1)
- Affekt (1)
- Aggregation (1)
- Alkaloid (1)
- Amygdala (1)
- Ancistrocladaceae (1)
- Animales Nervensystem (1)
- Annotation (1)
- Anti-infective (1)
- Antigen CD28 (1)
- Antigenrezeptor (1)
- Anxiety (1)
- Apolipoprotein E (1)
- Attention (1)
- Audiologie (1)
- Auditorische Neuropathie (1)
- Autoantikörper (1)
- Autoimmunität (1)
- Autophagie <Physiologie> (1)
- Autophagosom (1)
- Autophagozytose (1)
- Autoproteolysis (1)
- B-MYB (1)
- Behaviour (1)
- Bildbearbeitung (1)
- Bildgebung intakten Knochens (1)
- Bildverarbeitung (1)
- Biofilm (1)
- Biofilmarchitektur (1)
- Bioinformatik (1)
- Biokinetics (1)
- Biomaterial (1)
- Biomedicine (1)
- Bioreaktor (1)
- Brustkrebs (1)
- C/EBP (1)
- C5aR1-Antagonist (1)
- CAR T-Zelltherapie (1)
- CDC42 (1)
- Cadherine (1)
- Candida albicans (1)
- Cataglyphis (1)
- Cdh13 (1)
- Cell migration (1)
- Chimeric Antigen Receptor (1)
- Chimärer Antigenrezeptor (1)
- Chlamydia trachomatis (1)
- Chronisch-myeloische Leukämie (1)
- Chronische Nierenerkrankung (1)
- Chronobiologie (1)
- CoQ10 (1)
- Computersimulation (1)
- Corti-Organ (1)
- Cushing-Syndrom (1)
- Cytologie (1)
- DNA damage (1)
- DNA-Schäden (1)
- DRG (1)
- DROSHA (1)
- Darmwandnervensystem (1)
- Dendritic cell (1)
- Dendritische Zelle (1)
- Depression (1)
- Development (1)
- Diagnostic Imaging Exams (1)
- Domäne <Biochemie> (1)
- Dopamin (1)
- Dosimetry (1)
- Drosophila (1)
- Drosophila melanogaster (1)
- Drug targets (1)
- Drug testing (1)
- EMT (1)
- Ecology (1)
- Eierstockkrebs (1)
- Elektrode (1)
- Elektrospinnen (1)
- Emotionales Verhalten (1)
- Enterisches Nervensystem (1)
- Entwicklung (1)
- Entzündung (1)
- Experimentelle Autoimmune Enzephalomyelitis (1)
- Eye irritation (1)
- Fear Generalization (1)
- Fear Learning (1)
- Flugzeitmassenspektrometrie (1)
- Fremdkörpermodell (1)
- Frühdiagnostik (1)
- Furchkonditionierung (1)
- Furcht (1)
- Furchtgeneralisierung (1)
- G Protein-coupled receptor (1)
- G-Protein gekoppelte Rezeptor (1)
- G-quadruplex (1)
- Ga-68-labelled Peptides (1)
- Gedächtnis (1)
- Gen-Umwelt Interaktion (1)
- Gene by Environment (1)
- Generalisierung (1)
- Genetics (1)
- Genmutation (1)
- Genom (1)
- Genome Annotation (1)
- Gestational diabetes (1)
- Gestationsdiabetes (1)
- Gewebemodell (1)
- Glucose metabolism (1)
- Glukosemetabolismus (1)
- Glycerin-3-phosphat (1)
- Glycerinphosphate (1)
- Graft versus host disease (1)
- GvHD (1)
- HNE (1)
- Haarzelle (1)
- Helicasen (1)
- Herz-Kreislauf-Erkrankung (1)
- Herzmuskelzelle (1)
- Herzschrittmacher (1)
- Hippo pathway (1)
- Hippocampus (1)
- Host Genome Integrity (1)
- Human Herpesvirus 6 (1)
- Humanes Herpesvirus 6 (1)
- Immunologe (1)
- In vitro (1)
- Induzierte pluripotente Stammzelle (1)
- Inflammatory Pain (1)
- Inflammatory pain (1)
- Insulin (1)
- Integrine (1)
- Invasion (1)
- Ionenkanal (1)
- Isolation (1)
- K-RAS (1)
- KDELR2 (1)
- Kardiomyozyt (1)
- Kardiovaskuläre Krankheit (1)
- Kernspintomografie (1)
- Kohlenstoff (1)
- Kohlenstofffaser (1)
- Kollektive Invasion (1)
- Komplement C5a (1)
- Komplement C5a Rezeptor 1 (1)
- Konditionierung (1)
- Kongo (1)
- Kraniosynostose (1)
- Krebs (1)
- Krebs <Medizin> (1)
- Latrophilin (1)
- Learning walk (1)
- Leichte kognitive Beeinträchtigung (1)
- Lernen (1)
- Lernverhalten (1)
- Library Screening (1)
- Lichtblattmikroskopie (1)
- Lichtscheibenmikroskopie (1)
- Light sheet microscopy (1)
- Lipidom (1)
- Lipidomics (1)
- Lung (1)
- Lunge (1)
- Lungentumor (1)
- Lysosom (1)
- MMB (1)
- MMB complex (1)
- MRI (1)
- MRSA (1)
- Magnetic Resonance Imaging (1)
- Makrokolonie (1)
- Mamma carcinoma (1)
- Mammakarzinom (1)
- Masern-Virus (1)
- Mass spectrometry (1)
- Massenspektrometrie (1)
- Measles virus (1)
- Mechanisms of Social Attention (1)
- Mechanosensation (1)
- Megakaryopoese (1)
- Megakaryozytopoese (1)
- Membrane transporters (1)
- Membrantransporter (1)
- Meningokokken-Sepsis (1)
- Meniskus (1)
- Meniskusimplantat (1)
- Method development (1)
- Methodenentwicklung (1)
- Mikroarray basierte vergleichende Genomhybridisierung (Array-CGH) (1)
- Mikroskopie (1)
- Modell (1)
- Molekulare Zielstrukturen (1)
- Molekulargenetik (1)
- Multiphotonenmikroskopie (1)
- Multiple Sklerose (1)
- Multiples Myelom (1)
- Muscarinrezeptor (1)
- Mutation (1)
- Myrmecology (1)
- N2pc (1)
- NIR-Spektroskopie (1)
- Nahrungserwerb (1)
- Nanofaser (1)
- Naphthylisochinolinalkaloide (1)
- Naphthylisoquinoline (1)
- Nephroblastom (1)
- Nephrogenese (1)
- Neuroanatomie (1)
- Neurodevelopmental Disorder (1)
- Neuropathologie (1)
- Next Generation Sequencing (NGS) (1)
- Nicht-kleinzelliges Bronchialkarzinom (1)
- Nociceptor (1)
- Nuclear Medicine (1)
- Nucleus subthalamicus (1)
- Optimal foraging (1)
- OxPL (1)
- Oxidized Phospholipids (1)
- Oxidized phospholipids (1)
- PRKACA (1)
- Paternal age and BMI effects (1)
- Pediatric Nuclear Medicine (1)
- Pediatric Patients (1)
- Phosphatase (1)
- Phosphatasen (1)
- Phosphoglykolat (1)
- Phosphoglykolat-Phosphatase (1)
- Phospholipide (1)
- Photoreceptor (1)
- Physiologie (1)
- Plasmozytom (1)
- Prefrontal cortex (1)
- Protein crosslinking (1)
- Protein interactions (1)
- Proteininteraktion (1)
- Proteininteraktionen (1)
- Proteinkinase A (1)
- Proteinkinase D (1)
- Proteinquervernetzungen (1)
- Proteinsynthese (1)
- Präfrontaler Cortex (1)
- Prävention (1)
- REDD1 (1)
- RNA Sequencing (1)
- RNA protein interactions (1)
- RNA secondary structures (1)
- RNA-Seq (1)
- RNS (1)
- ROS (1)
- Radiation Protection (1)
- Radiation-associated Cancer Risk (1)
- Raphe (1)
- Regenerative Medizin (1)
- Reporter Cells (1)
- Reporterzellen (1)
- Rescue behaviour (1)
- Resistenz (1)
- RhoA (1)
- Rhodopsin (1)
- Risk Assessment (1)
- SGLT (1)
- SIX1 (1)
- SREBP (1)
- Schlaganfall (1)
- Schmerzforschung (1)
- Schmerztherapie (1)
- Screening (1)
- Sekundärprävention (1)
- Signaltransduktion (1)
- Sinneszelle (1)
- Small RNA (1)
- Soziale Wahrnehmung (1)
- Sphingosine-1-phosphate (1)
- Sphingosine-1-phosphats (1)
- Spred-Proteine (1)
- Staphylococcus aureus (1)
- Stechameisen (1)
- Stimulation (1)
- Stoffwechsel (1)
- Structural elucidation (1)
- Suspensionskultur (1)
- TLR3 (1)
- TMEM16F (1)
- TRPA1 channel (1)
- TWEAK (1)
- Tagesrhythmus (1)
- Tamoxifen (1)
- Taufliege (1)
- Tc-99m-MAG3 Scans (1)
- Therapie (1)
- Therapiesimulation (1)
- Thrombo-inflammation (1)
- Thrombosis (1)
- Thrombozytopenie (1)
- Time-of-flight (1)
- Tissue engineering (1)
- Trailmaking Test (1)
- Transgener Organismus (1)
- Transplantat-Wirt-Reaktion (1)
- Tryptophan hydroxylase (1)
- Tumor (1)
- Tumorzelle (1)
- Ultrashort echo time - UTE (1)
- Vaskularisierung (1)
- Vesikel (1)
- Wechselwirkungen (1)
- Wilms tumor (1)
- Wilms-Tumor (1)
- Wirkstofftestung (1)
- ZFAND1 (1)
- Zell Migration (1)
- Zell-Migration (1)
- Zellkultur (1)
- Zellteilung (1)
- actin cytoskeleton (1)
- actin-binding proteins (1)
- autophagocytosis (1)
- autophagosome (1)
- beige adipocytes (1)
- biofilm architecture (1)
- biological scaffolds (1)
- bioreactor (1)
- blood brain barrier (1)
- blood cerebrospinal fluid barrier (1)
- cancer (1)
- cardiac tissue (1)
- cellular model (1)
- chronic kidney disease (1)
- circadian rhythms (1)
- collective invasion (1)
- coronary heart disease (1)
- cyclase-associated protein (1)
- cyclase-associated protein 2 (1)
- cytokinesis (1)
- decellularization (1)
- dopamine (1)
- electrode scaffold (1)
- emotion (1)
- endothelial cells (1)
- evolution (1)
- fluorescence microscopy (1)
- functional connectivity (1)
- guanylyl cyclase (GC) (1)
- hiPSC aggregation (1)
- iPSC (1)
- in situ microscopy (1)
- induced pluripotent stem cells (1)
- inherited macrothrombocytopenia (1)
- intact bone imaging (1)
- integrins (1)
- interactions (1)
- ischemic stroke (1)
- kardiovaskuläre Risikofaktoren (1)
- kidney development (1)
- koronare Herzerkrankung (1)
- learning (1)
- lightsheet microscopy (1)
- lung cancer (1)
- macrocolony (1)
- measles virus (1)
- megakaryocyte (1)
- memory (1)
- meniscus implant (1)
- micro processor complex (1)
- microRNA (1)
- mitosis (1)
- mitotic gene expression (1)
- multi-photon microscopy (1)
- multiphoton microscopy (1)
- object segmentation (1)
- oscillations (1)
- p53 (1)
- platelets (1)
- podosome formation (1)
- polarization (1)
- protein kinase D1 (1)
- reactive oxygen species (1)
- restriction factors (1)
- reverse genetics (1)
- secondary prevention (1)
- sensorische Neurone (1)
- shRNA (1)
- short neuropeptide F (1)
- single cell anatomy (1)
- small RNA (1)
- subthalamic nucleus (1)
- therapy simulation (1)
- tissue engineering (1)
- transgenes Modell (1)
- two-component (1)
- ubiquitin (1)
- vascularization (1)
- zielgerichtete Therapien (1)
- β3 adrenergic receptor (1)
Institute
- Graduate School of Life Sciences (69) (remove)
Sonstige beteiligte Institutionen
- Bio-Imaging Center Würzburg (1)
- CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - the development agency of the Brazilian Federal Government (1)
- DAAD - Deutscher Akademischer Austauschdienst (1)
- Institute for Biochemistry I, University of Cologne (1)
- Medizinische Klinik und Poliklinik 1, Abteilung Kardiologie (1)
- Medizinische Klinik und Poliklinik 1, Abteilung Nephrologie (1)
Die Phosphoglykolat-Phosphatase PGP (früher auch als AUM bezeichnet) wurde in unserem Labor als Mitglied der HAD-Typ-Phosphatasen identifiziert. Die genetische Inaktivierung des Enzyms im gesamten Mausorganismus führt ab E8.5 zu einer Wachstumsverzögerung muriner Embryonen und bis E12.5 schließlich zu deren Tod. Im Gegensatz dazu sind Mäuse mit einer PGP-Inaktivierung in hämatopoetischen Zellen und im Endothel lebensfähig und phänotypisch unauffällig. Neue Erkenntnisse schreiben dem Enzym neben einer Aktivität gegenüber Phosphoglykolat auch Aktivitäten gegenüber Glycerin-3-phosphat (G3P), P-Erythronat und P-Lactat zu. Da diese Phosphatase-Aktivitäten Auswirkungen auf den Lipidstoffwechsel nahelegen, wurde in der vorliegenden Arbeit mittels massenspektrometrischer Methoden der Einfluss der Phosphoglykolat-Phosphatase auf den Metabolismus von Signal-, Membran- und Speicherlipiden in murinen Embryonen und Lymphozyten untersucht.
Nach Inaktivierung der PGP im gesamten Organismus wurden in E8.5-Embryonen erhöhte Diacylglycerin (DG)-, Triacylglycerin (TG)- und Sphingomyelin (SM)-Spiegel gemessen, während niedrigere Phosphatidylcholin (PC)-Level vorlagen.
In PGP-inaktivierten Lymphozyten waren G3P-, DG-, TG-, PC- und SM-Level nicht verändert. Dafür kam es zu signifikanten Erhöhungen der Phosphatidylglycerol (PG*)- und Cardiolipin (CL)-Spiegel.
Zusammenfassend konnte gezeigt werden, dass die PGP in unterschiedlichen Geweben differenzielle Effekte auf die Spiegel verschiedener Lipide hat. Dies deckt neue Funktionen der PGP für die Regulation des Lipidmetabolismus auf. Die vorliegende Arbeit stellt somit die Grundlage für weitere Untersuchungen über die genauen Ursachen und Folgen dieser Regulation dar und lässt auf eine wichtige Rolle der PGP als metabolische Phosphatase im Organismus schließen.
Das Multiple Myelom muss trotz stetiger Fortschritte im Hinblick auf die verfügbaren Therapieoptionen und die Krankheitsprognose weiterhin im Wesentlichen als eine unheilbare Erkrankung angesehen werden. Dies kann vor allem auf die große inter- und intraindividuelle Heterogenität des MM zurückgeführt werden, welche die Entwicklung gezielter molekularer Therapiestrategien erheblich erschwert. Hierbei stellen loss-of-function- Experimente, welche die Identifikation einzelner oder mehrerer potenziell therapeutisch relevanter Zielstrukturen durch die (kombinierte) Depletion von Proteinen ermöglichen, eine wichtige Säule dar, für deren Durchführung verschiedene Systeme mit jeweils eigenen Vor- und Nachteilen zur Verfügung stehen. Im Rahmen dieser Arbeit konnte die Etablierung eines auf RNA-Interferenz basierenden stabilen und induzierbaren Knockdownsystems durch Elektroporation von MM Zelllinien mit Einzel- und Mehrfach-shRNA-Vektoren abgeschlossen werden. Die Transfektion von tet-Repressor-exprimierenden Zellinien mit einer oder mehreren shRNAExpressionskassetten innerhalb eines Plasmidvektors ermöglicht durch die vollständige Repression der shRNA-Transkription im nicht-induzierten Zustand die Selektion erfolgreich transponierter Zellen ohne Effekt-vermittelte Bias und die Generierung großer Zellmengen für Versuchsreihen in vergleichsweise kurzer Zeit. Die Induktion der verschiedenen in dieser Arbeit evaluierten Einzel- und Mehrfach-shRNA-Konstrukte gegen (Kombinationen von) Zielstrukturen im Ras/MAPK- sowie im NFκB-Signalsystem mittels Doxyzyklin als Induktionsagens zeigte durchweg deutliche und den Erwartungen aus transienten Experimenten entsprechende Knockdownergebnisse. Auch die Resultate hinsichtlich funktioneller Readouts und zellphysiologischer Effekte der induzierten Knockouts stehen im Einklang mit vorangegangenen Experimenten und bestätigen somit die Äquivalenz des stabilen induzierbaren Systems zu transienten Ansätzen auf RNAi-Basis oder zu pharmakologischen Inhibitoren. Der hierbei erzielte hypomorphe Phänotyp innerhalb einer polyklonalen Zellpopulation bildet die Realität einer medikamentösen Blockade einer oder weniger Zielstrukturen einer heterogenen MM Tumorpopulation näherungsweise ab, weshalb das vorgestellte System ein hilfreiches, kosteneffizientes und leicht zu handhabendes Werkzeug für die Identifikation potenziell relevanter Zielstrukturen für molekulare Therapieansätze im Multiplen Myelom darstellt
Development and application of computational tools for RNA-Seq based transcriptome annotations
(2019)
In order to understand the regulation of gene expression in organisms, precise genome annotation is essential. In recent years, RNA-Seq has become a potent method for generating and improving genome annotations. However, this Approach is time consuming and often inconsistently performed when done manually. In particular, the discovery of non-coding RNAs benefits strongly from the application of RNA-Seq data but requires significant amounts of expert knowledge and is labor-intensive. As a part of my doctoral study, I developed a modular tool called ANNOgesic that can detect numerous transcribed genomic features, including non-coding RNAs, based on RNA-Seq data in a precise and automatic fashion with a focus on bacterial and achaeal species. The software performs numerous analyses and generates several visualizations. It can generate annotations of high-Resolution that are hard to produce using traditional annotation tools that are based only on genome sequences. ANNOgesic can detect numerous novel genomic Features like UTR-derived small non-coding RNAs for which no other tool has been developed before. ANNOgesic is available under an open source license (ISCL) at https://github.com/Sung-Huan/ANNOgesic.
My doctoral work not only includes the development of ANNOgesic but also its application to annotate the transcriptome of Staphylococcus aureus HG003 - a strain which has been a insightful model in infection biology. Despite its potential as a model, a complete genome sequence and annotations have been lacking for HG003. In order to fill this gap, the annotations of this strain, including sRNAs and their functions, were generated using ANNOgesic by analyzing differential RNA-Seq data from 14 different samples (two media conditions with seven time points), as well as RNA-Seq data generated after transcript fragmentation. ANNOgesic was
also applied to annotate several bacterial and archaeal genomes, and as part of this its high performance was demonstrated. In summary, ANNOgesic is a powerful computational tool for RNA-Seq based annotations and has been successfully applied to several species.
Bei der Multiplen Sklerose (MS) handelt es sich um eine Autoimmunerkrankung des zentralen Nervensystems (ZNS). Abhängig von der betroffenen ZNS-Region kann es zu vielfältigen Symptomen kommen. Neben neurologischen Symptomen verursacht durch ZNS-Läsionen leidet ein Großteil der MS-Patienten auch unter gastrointestinalen Funktionsstörungen. Diese gastrointestinalen Symptome wurden bisher eher auf Läsionen im Rückenmark zurückgeführt und nicht direkt in Verbindung mit der autoimmunen Ätiologie der Erkrankung gebracht.
In dieser Studie wurde das enterische Nervensystem (ENS) in einem B-Zell- und Antikörper-abhängigen Mausmodell der MS untersucht. Dafür wurde der Autoimmunprozess durch Immunisierung mit MP4, einem Fusionsprotein aus dem Myelin-Basischen-Protein (MBP) und dem Proteolipid-Protein (PLP), ausgelöst. Das ZNS und ENS wurden in den unterschiedlichen Erkrankungsstadien immunhistochemisch und elektronenmikroskopisch analysiert. Neben der Immunpathologie des ZNS konnte dabei eine Degeneration des ENS schon vor dem Einsetzen der ersten neurologischen Defizite nachgewiesen werden. Die ENS-Pathologie war antikörper-mediiert und ging einher mit einer verringerten gastrointestinalen Motilität sowie mit einer Gliose und Neurodegeneration des ENS.
Mithilfe von Immunpräzipitation und Massenspektrometrie konnten im ENS vier mögliche Zielstrukturen des Autoimmunprozesses identifiziert werden, was auf sog. epitope spreading hindeutet. Auch im Plasma von MS-Patienten konnten Antikörper gegen drei dieser Antigene nachgewiesen werden. Des Weiteren zeigten sich in Kolon-Resektaten von MS-Patienten erste Ansätze einer Neurodegeneration und Gliose des ENS.
In dieser Studie wurde zum ersten Mal ein direkter Zusammenhang zwischen der Autoimmunreaktion gegen das ZNS und einer simultanen Reaktion gegen das ENS gezeigt. Dies kann einen Paradigmenwechsel im Verständnis der Immunpathogenese der MS anstoßen und neue therapeutische und diagnostische Ansätze initiieren.
The role of multicellularity as the predominant microbial lifestyle has been affirmed by studies on the genetic regulation of biofilms and the conditions driving their formation. Biofilms are of prime importance for the pathology of chronic infections of the opportunistic human pathogen Staphylococcus aureus.
The recent development of a macrocolony biofilm model in S. aureus opened new opportunities to study evolution and physiological specialization in biofilm communities in this organism. In the macrocolony biofilm model, bacteria form complex aggregates with a sophisticated spatial organization on the micro- and macroscale. The central positive and negative regulators of this organization in S. aureus are the alternative sigma factor σB and the quorum sensing system Agr, respectively. Nevertheless, nothing is known on additional factors controlling the macrocolony morphogenesis.
In this work, the genome of S. aureus was screened for novel factors that are required for the development of the macrocolony architecture. A central role for basic metabolic pathways was demonstrated in this context as the macrocolony architecture was strongly altered by the disruption of nucleotide and carbohydrate synthesis. Environmental signals further modulate macrocolony morphogenesis as illustrated by the role of an oxygen-sensitive gene regulator, which is required for the formation of complex surface structures. A further application of the macrocolony biofilm model was demonstrated in the study of interstrain interactions. The integrity of macrocolony communities was macroscopically visibly disturbed by competitive interactions between clinical isolates of S. aureus.
The results of this work contribute to the characterization of the macrocolony biofilm model and improve our understanding of developmental processes relevant in staphylococcal infections. The identification of anti-biofilm effects exercised through competitive interactions could lead to the design of novel antimicrobial strategies targeting multicellular bacterial communities.
The Myb-MuvB (MMB) multiprotein complex is a master regulator of cell cycle-dependent gene expression. Target genes of MMB are expressed at elevated levels in several different cancer types and are included in the chromosomal instability (CIN) signature of lung, brain, and breast tumors.
This doctoral thesis showed that the complete loss of the MMB core subunit LIN9 leads to strong proliferation defects and nuclear abnormalities in primary lung adenocarcinoma cells. Transcriptome profiling and genome-wide DNA-binding analyses of MMB in lung adenocarcinoma cells revealed that MMB drives the expression of genes linked to cell cycle progression, mitosis, and chromosome segregation by direct binding to promoters of these genes. Unexpectedly, a previously unknown overlap between MMB-dependent genes and several signatures of YAP-regulated genes was identified. YAP is a transcriptional co-activator acting downstream of the Hippo signaling pathway, which is deregulated in many tumor types. Here, MMB and YAP were found to physically interact and co-regulate a set of mitotic and cytokinetic target genes, which are important in cancer. Furthermore, the activation of mitotic genes and the induction of entry into mitosis by YAP were strongly dependent on MMB. By ChIP-seq and 4C-seq, the genome-wide binding of MMB upon YAP overexpression was analyzed and long-range chromatin interaction sites of selected MMB target gene promoters were identified. Strikingly, YAP strongly promoted chromatin-association of B-MYB through binding to distal enhancer elements that interact with MMB-regulated promoters through chromatin looping.
Together, the findings of this thesis provide a so far unknown molecular mechanism by which YAP and MMB cooperate to regulate mitotic gene expression and suggest a link between two cancer-relevant signaling pathways.
Herzschrittmachersysteme sind eine weitverbreitete Möglichkeit Herz-Kreislauf-Erkrankungen zu behandeln. Wegen der natürlichen Reaktion des Immunsystems auf Fremdkörper, erfolgt aber eine fortschreitende Verkapselung der Herzschrittmacherelektrode. Die Folge ist eine ansteigende Verminderung der Stimulationseffizienz durch Erhöhung der Anregungsschwelle. Die Integration der Elektrode in das Gewebe ist dabei mangelhaft und wird bestimmt durch Implantateigenschaften wie Größe, Flexibilität und Dimensionalität. Um die Integration zu verbessern, stellen dreidimensionale (3D) bzw. gewebeartige Elektroden eine Alternative zu den derzeit verwendeten planaren Metallelektroden dar. Zur Entwicklung einer leitfähigen, 3D und faserförmigen Elektrode wurden in dieser Arbeit Kohlenstoff-Nanofaser-Scaffolds über Elektrospinnen hergestellt. Durch die Modifikation des Fasergerüstes mit Natriumchlorid (NaCl) während der Scaffoldherstellung, konnte das Fasernetzwerk aufgelockert und Poren generiert werden. Die Kohlenstofffaser-Elektroden zeigten einen effizienten Energieübertrag, welcher vergleichbar mit heutigen Titannitrid (TiN) -Elektroden ist. Die Auflockerung des Fasergewebes hatte eine verbesserte Flexibilität des Faserscaffolds zu Folge. Neben der Flexibilität, konnte auch die Infiltration von Zellen in das poröse Faserscaffold erheblich verbessert werden. Dabei konnten Fibroblasten durch das gesamte Scaffold migrieren. Die Kompatibilität mit kardialen Zellen, die Grundvoraussetzung von Herzschrittmacherelektroden, wurde in vitro nachgewiesen. Durch die Kombination aus dem 3D-Elektrodengerüst mit einer Co-Kultur aus humanen Kardiomyozyten, mesenchymalen Stammzellen und Fibroblasten, erfolgte eine Einbettung der Elektrode in funktionelles kardiales Gewebe. Dadurch konnte ein lebender Gewebe-Elektroden-Hybrid generiert werden, welcher möglicherweise die Elektrode vor Immunzellen in vivo abschirmen kann. Eine Zusammenführung der hybriden Elektrode mit einen Tissue-Engineerten humanen kardialen Patch in vitro, führte zu Bildung einer nahtlosen Elektronik-Gewebe-Schnittstelle. Die fusionierte Einheit wurde abschließend auf ihre mechanische Belastbarkeit getestet und konnte über einen Elektroden-Anschluss elektrisch stimuliert werden.
Chronic Kidney Disease as an Important Co-morbid Condition in Coronary Heart Disease Patients
(2019)
In patients with coronary heart disease (CHD) the control of the modifiable “traditional” cardiovascular risk factors such as hypertension, dyslipidemia, diabetes, achieving/maintaining normal body weight and smoking cessation is of major importance to improve prognosis. Guideline recommendations for secondary CHD prevention include specific treatment targets for blood pressure, lipid levels, and markers of glucose metabolism for both younger and older patients. Chronic kidney disease (CKD) has been identified as a “non-traditional” risk factor for worse outcome in CHD patients, as it is associated with a markedly increased risk for subsequent CV events and mortality.
The specific objectives of the current thesis-project are to investigate (a) the quality of care in a recent sample of German CHD patients and to investigate variation of risk factor control between younger and elder patients (≤70 versus >70 years), (b) to analyze the prevalence of CKD across Europe in stable CHD patients in the outpatient setting and during a hospital stay for CHD, (c) to investigate the level of awareness of CKD in German CHD patients and their treating physicians.
Data from the European-wide EUROASPIRE IV study were used that include data on 7998 CHD patients in the ambulatory setting (study visit) and during a hospital stay for CHD (index). The German EUROASPIRE IV study center in Würzburg recruited 536 patients in 2012-2013. Risk factor control was compared against the current recommendations of the European Society of Cardiology. CKD was described by stages of glomerular filtration rate (eGFR) and albuminuria. German patients were asked in an additional kidney specific module whether they have ever been told by a physician about renal impairment. The fact that CKD or acute kidney injury (AKI) was mentioned in prominent parts of the hospital discharge letter as well as correct ICD-coding of CKD or AKI served as a proxy for physician’s awareness of CKD.
The majority of German CHD patients was treated with the recommended drug therapies including e.g. β-blockers, anti-platelets and statins. However, treatment targets for blood pressure and LDL-cholesterol levels were not achieved in many patients (45% and 53%, respectively) and glycemic control in diabetic CHD patients with HbA1-levels <7% was insufficient (61%). A minority of patients reported on current smoking (10%), but unhealthy life-styles e.g. overweight/obesity (85%/37%) were frequent. Patterns of care differed between younger and older CHD patients while older patients were less likely to receive the recommended medical CHD-therapy, were more likely to have uncontrolled blood pressure and also to be diabetic. However, a greater proportion of diabetic patients >70 years was achieving the HbA1c target, and less elder patients were current smokers or were obese. About 17% of patients on average had CKD (eGFR< 60 ml/min/1.73m²) in the entire European sample at the study visit, and an additional 10% had albuminuria despite preserved eGFR, with considerable variation among countries. Impaired kidney function was observed in every fifth patient admitted for CHD in the entire European dataset of the EUROASPIRE IV study. Of the German CHD patients with CKD at the study visit, only a third were aware of their renal impairment. A minority of these patients was being seen by nephrologists, however, with a higher likelihood of CKD awareness and specialist care in more advanced stages of CKD. About a third of patients admitted for CHD showed either CKD or AKI during the hospital stay, but the discharge letter mentioned chronic or acute kidney disease only in every fifth of these patients. In contrast, correct ICD coding of CKD or AKI was more complete, but still suboptimal.
In summary, quality of secondary prevention in German CHD patients indicates considerably room for improvement, with life-style modifications may become an even greater factor in prevention campaigns than medical treatment into certain target ranges. Preventive therapies should also consider different needs in older individuals acknowledging physical and mental potential, other comorbidities and drug-interactions with co-medication. CKD is common in CHD patients, not only in the elderly. Since CHD and CKD affect each other and impact on worse prognosis of each other, raising the awareness of CKD among patients and physicians and considering CKD in medical therapy may improve prognosis and slow disease progression of CHD as well as CKD.
Hematopoietic stem cell transplantation is a curative therapy for malignant diseases of the haematopoietic system. The patients first undergo chemotherapy or irradiation therapy which depletes the majority of tumour cells before they receive the transplant, consisting of haematopoietic stem cells and mature T cells from a healthy donor. The donor T cells kill malignant cells that have not been eliminated by the conditioning therapy (graft versus leukaemia effect, GvL), and, therefore, are crucially required to prevent relapse of the tumour. However, the donor T cells may also severely damage the patient’s organs causing acute graft versus host disease (aGvHD). In mice, aGvHD can be prevented by interfering with the co-stimulatory CD28 signal on donor T cells. However, experimental models using conventional CD28 knockout mice as T cell donors or αCD28 antibodies have some disadvantages, i.e. impaired T cell development in the thymus of CD28 knockout mice and systemic CD28 blockade with αCD28 antibodies. Thus, it remains unclear how CD28 co-stimulation on different donor T cell subsets contributes to the GvL effect and aGvHD, respectively.
We developed mouse models of aGvHD and the GvL effect that allowed to selectively delete CD28 on certain donor T cell populations or on all donor T cells. CD4+ conventional T cells (Tconv cells), regulatory T cells (Treg cells) or CD8+ T cells were isolated from either Tamoxifen-inducible CD28 knockout (iCD28KO) mice or their wild type (wt) littermates. Allogeneic recipient mice were then transplanted with T cell depleted bone marrow cells and different combinations of iCD28KO and wt T cell subsets. Tamoxifen treatment of the recipients caused irreversible CD28 deletion on the iCD28KO donor T cell population. In order to study the GvL response, BCL-1 tumour cells were injected into the mice shortly before transfer of the T cells.
CD4+ Tconv mediated aGvHD was efficiently inhibited when wt Treg cells were co-transplanted. In contrast, after selective CD28 deletion on donor Treg cells, the mice developed a late and lethal flare of aGvHD, i.e. late-onset aGvHD. This was associated with a decline in iCD28KO Treg cell numbers around day 20 after transplantation. CD28 ablation on either donor CD4+ Tconv cells or CD8+ T cells reduced but did not abrogate aGvHD. Moreover, iCD28KO and wt CD8+ T cells were equally capable of killing allogeneic target cells in vivo and in vitro. Due to this sufficient anti-tumour activity of iCD28KO CD8+ T cells, they had a therapeutic effect in our GvL model and 25% of the mice survived until the end of the experiment (day 120) without any sign of the malignant disease. Similarly, CD28 deletion on all donor T cells induced long-term survival. This was not the case when all donor T cells were isolated from wt donor mice. In contrast to the beneficial outcome after CD28 deletion on all donor T cells or only CD8+ T cells, selective CD28 deletion on donor CD4+ Tconv cells completely abrogated the GvL effect due to insufficient CD4+ T cell help from iCD28KO CD4+ Tconv cells.
This study demonstrates that therapeutic inhibition of the co-stimulatory CD28 signal in either all donor T cells or only in CD8+ T cells might protect patients from aGvHD without increasing the risk of relapse of the underlying disease. Moreover, deletion of CD28 on donor Treg cells constitutes a mouse model of late-onset aGvHD which can be a useful tool in aGvHD research.
Protein quality control systems are critical for cellular proteostasis and survival under stress conditions. The ubiquitin proteasome system (UPS) plays a pivotal role in proteostasis by eliminating misfolded and damaged proteins. However, exposure to the environmental toxin arsenite results in the accumulation of polyubiquitylated proteins, indicating an overload of the UPS. Arsenite stress induces the rapid formation of stress granules (SGs), which are cytoplasmic assemblies of mRNPs stalled in translation initiation. The mammalian proteins ZFAND2A/B (also known as AIRAP and AIRAPL, respectively) bind to the 26S proteasome, and ZFAND2A has been shown to adapt proteasome activity to arsenite stress. They belong to a small subfamily of AN1 type zinc finger containing proteins that also comprises the unexplored mammalian member ZFAND1 and its yeast homolog Cuz1.
In this thesis, the cellular function of Cuz1 and ZFAND1 was investigated. Cuz1/ZFAND1 was found to interact with the ubiquitin-selective, chaperone-like ATPase Cdc48/p97 and with the 26S proteasome. The interaction between Cuz1/ZFAND1 and Cdc48/p97 requires a predicted ubiquitin-like domain of Cuz1/ZFAND1. In vivo, this interaction was strongly dependent on acute arsenite stress, suggesting that it is a part of the cellular arsenite stress response. Lack of Cuz1/ZFAND1 caused a defect in the clearance of arsenite induced SG clearance. ZFAND1 recruits both, the 26S proteasome and p97, to arsenite-induced SGs for their normal clearance. In the absence of ZFAND1, SGs lack the 26S proteasome and p97, accumulate defective ribosomal products and become aberrant. These aberrant SGs persist after arsenite removal and undergo degradation via autophagy. ZFAND1 depletion is epistatic to the expression of pathogenic mutant p97 with respect to SG clearance, suggesting that ZFAND1 function is relevant to the multisystem degenerative disorder, inclusion body myopathy associated with Paget’s disease of bone and frontotemporal dementia and amyotrophic lateral sclerosis (IBMPFD/ALS).
Herein described are the isolation, structural elucidation, and biological evaluation of highly thrilling monomeric and dimeric new naphthylisoquinoline alkaloids from A. ealaensis. The separation, chiral resolution, and characterization of a series of stereoisomeric 2,3-dihydrobenzofuran neolignans are also reported. The analytical and phytochemical analysis on two Congolese antimalarial herbal drugs is part of the last chapter of the results. In this last case, major concerns on widely used Congolese herbal drugs are discussed.
Measles is an extremely contagious vaccine-preventable disease responsible
for more than 90000 deaths worldwide annually. The number of deaths has
declined from 8 million in the pre-vaccination era to few thousands every year due
to the highly efficacious vaccine. However, this effective vaccine is still unreachable
in many developing countries due to lack of infrastructure, while in developed
countries too many people refuse vaccination. Specific antiviral compounds are not
yet available. In the current situation, only an extensive vaccination approach
along with effective antivirals could help to have a measles-free future. To develop
an effective antiviral, detailed knowledge of viral-host interaction is required.
This study was undertaken to understand the interaction between MV and
the innate host restriction factor APOBEC3G (A3G), which is well-known for its
activity against human immunodeficiency virus (HIV). Restriction of MV
replication was not attributed to the cytidine deaminase function of A3G, instead,
we identified a novel role of A3G in regulating cellular gene functions. Among two
of the A3G regulated host factors, we found that REDD1 reduced MV replication,
whereas, KDELR2 hampered MV haemagglutinin (H) surface transport thereby
affecting viral release. REDD1, a negative regulator of mTORC1 signalling
impaired MV replication by inhibiting mTORC1. A3G regulated REDD1
expression was demonstrated to inversely correlate with MV replication. siRNA
mediated silencing of A3G in primary human blood lymphocytes (PBL) reduced
REDD1 levels and simultaneously increased MV titres. Also, direct depletion of
REDD1 improved MV replication in PBL, indicating its role in A3G mediated
restriction of MV. Based on these finding, a new role of rapamycin, a
pharmacological inhibitor of mTORC1, was uncovered in successfully diminishing
MV replication in Vero as well as in human PBL. The ER and Golgi resident
receptor KDELR2 indirectly affected MV by competing with MV-H for cellular
chaperones. Due to the sequestering of chaperones by KDELR2, they can no longer
assist in MV-H folding and subsequent surface expression. Taken together, the two
A3G-regulated host factors REDD1 and KDELR2 are mainly responsible for
mediating its antiviral activity against MV.
Die Einhaltung eines gesunden Lebensstils, einschließlich der Behandlung modifizierbarer kardiovaskulärer Risikofaktoren, beeinflusst maßgeblich die Entstehung und Progression von Herz-Kreislauf-Erkrankungen (HKE). So reduziert eine ausgewogene Ernährungsweise, ausreichend körperliche Aktivität, Tabakverzicht, das Halten des Normalgewichtes sowie die Behandlung einer Hypertonie, Hyperlipidämie und Diabetes mellitus, die kardiovaskuläre Morbidität und Mortalität.
Die vorliegende Arbeit widmet sich (a) der Prävalenz und leitliniengerechten Kontrolle kardiovaskulärer Risikofaktoren von Teilnehmern aus der Allgemeinbevölkerung der STAAB Kohortenstudie („Häufigkeit und Einflussfaktoren auf frühe Stadien A und B der Herzinsuffizienz in der Bevölkerung“) sowie der Schätzung des 10-Jahres Risikos für tödliche HKE in diesem Kollektiv. Weiterhin wurde (b) der Einfluss von medikamentenbezogenen Überzeugungen auf die Blutdruckkontrolle von Teilnehmern der STAAB Kohortenstudie untersucht. Schließlich wurde (c) der Erhalt von ärztlichen Lebensstilempfehlungen sowie deren Determinanten bei Teilnehmern der STAAB Kohortenstudie sowie der EUROASPIRE IV Studie („European Action on Secondary and Primary Prevention by Intervention to Reduce
Events“) in Deutschland betrachtet.
Die STAAB Kohortenstudie untersucht die frühen asymptomatischen Formen der Herzinsuffizienz-Stadien A und B in einer repräsentativen Stichprobe von 5.000 Personen
ohne symptomatische Herzinsuffizienz im Alter von 30 bis 79 Jahren aus der Allgemeinbevölkerung mit Wohnsitz in der Stadt Würzburg.
Die EUROASPIRE IV Studie untersuchte bei 7.998 Koronarpatienten im Alter von 18 bis 79
Jahren aus insgesamt 24 Europäischen Ländern (536 Patienten aus Deutschland) im Zeitraum 2012 bis 2013 die Risikofaktoren sowie die Umsetzung der leitliniengerechten Versorgung und Prävention von HKE im europäischen Vergleich. Die Datenerhebung beider Studien erfolgte durch ein geschultes Studienpersonal nach standardisierten Vorgaben.
Die Prävalenz und Kontrolle kardiovaskulärer Risikofaktoren nach den aktuellen Vorgaben der „European Society of Cardiology“ (ESC) wurde bei insgesamt 1.379 Teilnehmern, die zwischen Dezember 2013 und April 2015 an der STAAB Kohortenstudie teilgenommen haben, untersucht. Es zeigte sich eine hohe Prävalenz der kardiovaskulären Risikofaktoren Hypertonie (31.8%), Hyperlipidämie (57.6%) und Diabetes mellitus (3.5%). Hierbei erreichten
trotz Pharmakotherapie über die Hälfte der Teilnehmer mit einem Bluthochdruck (52.7%) oder erhöhten LDL-Cholesterinwerten (56.7%) sowie 44.0% der Personen mit einem Diabetes mellitus die empfohlenen Grenzwerte nicht. Weiterhin wurde erstmalig zu Studienbesuch eine Hypertonie (36.0%), Hyperlipidämie (54.2%) oder ein Langzeitzuckerwert (HbA1c) >6.5% (23.3%) detektiert. In der jüngsten Altersgruppe (30-39 Jahre) fand sich der höchste Anteil von unbekanntem Bluthochdruck (76.5%) sowie hohem LDL-Cholesterin (78.0%) und die Altersgruppe 60-69 Jahren wies mit 43.5% die höchste Prävalenz für einen bislang nicht detektierten HbA1c >6.5% auf. Die Akkumulation von drei oder mehr kardiovaskulären Risikofaktoren war mit dem männlichen Geschlecht, einem höheren Alter und einem niedrigeren Bildungsgrad assoziiert. Von 980 mittels SCORE („Systematic Coronary Risk Evaluation“) Risiko-Chart untersuchten Teilnehmern befanden sich jeweils 56.6%, 35.8% und 7.5% in der niedrigen, mittleren und hohen bis sehr hohen SCORE-Risikogruppe für tödliche HKE. Das Hochrisiko-Kollektiv für tödliche HKE war vorwiegend männlich und wies häufiger eine Hypertonie oder ein hohes LDL-Cholesterin auf.
Der Einfluss von Überzeugungen gegenüber antihypertensiver Medikation auf die Blutdruckkontrolle wurde an 293 Teilnehmern, die von Oktober 2014 bis März 2017 an der STAAB Kohortenstudie teilgenommen haben, untersucht. Auf ihre Medikamente gesundheitlich angewiesen zu sein gaben 87% der Teilnehmer an, 78.1% stimmten der Aussage zu, dass ihre Medikamente sie vor einer Verschlechterung ihrer Gesundheit schützen. Es zeigte sich ein inverser Zusammenhang zwischen einem höheren Maß an Bedenken gegenüber der verordneten blutdrucksenkenden Medikation und einer besseren Blutdruckkontrolle bei Frauen. Ein signifikanter Zusammenhang zwischen Bedenken gegenüber einer antihypertensiven Medikation und der Blutdruckkontrolle bei Männern ließ sich hingegen nicht feststellen. Es konnten keine statistisch signifikanten Assoziationen für die Notwendigkeit von Medikation in der vorliegen Untersuchung gezeigt werden.
Die Häufigkeit und Determinanten für die Empfehlung eines ärztlichen Lebensstils wurde bei 665 Teilnehmern der STAAB Kohortenstudie ohne vorbestehende HKE (Primärprävention) und bei 536 Koronarpatienten der EUROASPIRE IV Studie (Sekundärprävention) untersucht.
Mit Ausnahme der Empfehlung zum Rauchverzicht erhielten die Patienten der EUROASPIRE IV Studie häufiger ärztliche Lebensstilempfehlungen verglichen mit Teilnehmern der STAAB Kohortenstudie: (Rauchverzicht: STAAB 44.0%, EUROASPIRE 36.7%; Gewichtsreduktion: STAAB 43.9%, EUROASPIRE 69.2%; körperliche Aktivität steigern: STAAB 52.1%, EUROASPIRE 71.4%; gesundes Ernährungsverhalten: STAAB 43.9%, EUROASPIRE 73.1%). Die Chance für den Erhalt von mindestens 50% aufgrund der individuellen Risikofaktoren adäquaten ärztlichen Lebensstilempfehlungen war bei STAAB Teilnehmern mit offensichtlichen oder beobachtbaren kardiovaskulären Risikofaktoren signifikant erhöht (BMI >25kg/m2, Hypertonie, Hyperlipidämie und Diabetes mellitus).
Hingegen erhielten Patienten mit einer vorbestehenden HKE signifikant häufiger eine ärztliche Lebensstilempfehlung bei einem Diabetes mellitus, wobei die Empfehlungshäufigkeit mit zunehmendem Alter abnahm. Die weitergehende nicht publizierte Analyse des Interaktions
Modells zeigte, dass der Zusammenhang zwischen dem Alter und der Empfehlungshäufigkeit bei Patienten mit bereits bestehender HKE stärker ausgeprägt war, als bei Teilnehmern der STAAB Kohortenstudie ohne koronare HKE. Weiterhin war der Zusammenhang zwischen einer adäquaten Lebensstilempfehlung und Hyperlipidämie bei Teilnehmern ohne koronares Ereignis signifikant stärker ausgeprägt, im Vergleich zu Patienten mit einer bereits bestehender HKE.
Die Ergebnisse zeigten ein erhebliches Potenzial für eine verbesserte Umsetzung leitliniengerechter Behandlung modifizierbarer kardiovaskulärer Risikofaktoren in der Primär- und Sekundärprävention. Vor dem Hintergrund einer hohen Anzahl kardiovaskulärer Risikofaktoren bei jungen Erwachsenen sollte die Bedeutung der Langzeitfolgen im Arzt
Patienten-Gespräch hervorgehoben und bei der Erarbeitung von Präventionsstrategien, insbesondere für junge Altersgruppen, Beachtung finden. Geschlechtsspezifische
Determinanten hinsichtlich der Kontrolle kardiovaskulärer Risikofaktoren sowie Befürchtungen gegenüber der Medikation sollten stärker im Arzt-Patientengespräch berücksichtigt werden.
Zur Stärkung der Compliance des Patienten bei der Umsetzung eines gesunden Lebensstils,
sollte der Arzt hinsichtlich der Bedeutung von Lebensstilintervention, aber auch im Umgang mit schwierigen Situationen, wie die Empfehlung einer Gewichtsreduktion, sensibilisiert und bei der richtigen Handhabung der Leitlinienempfehlung stärker unterstützt werden.
Characterization of novel rhodopsins with light-regulated cGMP production or cGMP degradation
(2019)
Photoreceptors are widely occurring in almost all kingdoms of life. They mediate the first step in sensing electromagnetic radiation of different wavelength. Absorption spectra are found within the strongest radiation from the sun and absorption usually triggers downstream signaling pathways. Until now, mainly 6 classes of representative photoreceptors are known: five water-soluble proteins, of these three classes of blue light-sensitive proteins including LOV (light-oxygen-voltage), BLUF (blue-light using FAD), and cryptochrome modules with flavin (vitamin B-related) nucleotides as chromophore; while two classes of yellow and red light-sensitive proteins consist of xanthopsin and phytochrome, respectively. Lastly, as uniquely integral membrane proteins, the class of rhodopsins can usually sense over a wide absorption spectrum, ranging from ultra-violet to green and even red light. Rhodopsins can be further divided into two types, i.e., microbial (type I) and animal (type II) rhodopsins. Rhodopsins consist of the protein opsin and the covalently bound chromophore retinal (vitamin A aldehyde). In this thesis, I focus on identification and characterization of novel type I opsins with guanylyl cyclase activity from green algae and a phosphodiesterase opsin from the protist Salpingoeca rosetta.
Until 2014, all known type I and II rhodopsins showed a typical structure with seven transmembrane helices (7TM), an extracellular N-terminus and a cytosolic C-terminus. The proven function of the experimentally characterized type I rhodopsins was membrane transport of ions or the coupling to a transducer which enables phototaxis via a signaling chain. A completely new class of type I rhodopsins with enzymatic activity was identified in 2014. A light-activated guanylyl cyclase opsin was discovered in the fungus Blastocladiella emersonii which was named Cyclop (Cyclase opsin) by Gao et al. (2015), after heterologous expression and rigorous in-vitro characterization. BeCyclop is the first opsin for which an 8 transmembrane helices (8TM) structure was demonstrated by Gao et al. (2015). Earlier (2004), a novel class of enzymatic rhodopsins was predicted to exist in C. reinhardtii by expressed sequence tag (EST) and genome data, however, no functional data were provided up to now. The hypothetical rhodopsin included an N-terminal opsin domain, a fused two-component system with histidinekinase and response regulator domain, and a C-terminal guanylyl cyclase (GC) domain. This suggested that there could be a biochemical signaling cascade, integrating light-induction and ATP-dependent phosphate transfer, and as output the light-sensitive cGMP production.
One of my projects focused on characterizing two such opsins from the green algae Chlamydomonas reinhardtii and Volvox carteri which we then named 2c-Cyclop (two-component Cyclase opsin), Cr2c-Cyclop and Vc2c-Cyclop, respectively. My results show that both 2c-Cyclops are light-inhibited GCs. Interestingly, Cr2c-Cyclop and Vc2c-Cyclop are very sensitive to light and ATP-dependent, whereby the action spectra of Cr2c-Cyclop and Vc2c-Cyclop peak at ~540 nm and ~560 nm, respectively. More importantly, guanylyl cyclase activity is dependent on continuous phosphate transfer between histidine kinase and response regulator. However, green light can dramatically block phosphoryl group transfer and inhibit cyclase activity. Accordingly, mutation of the retinal-binding lysine in the opsin domain resulted in GC activity and lacking light-inhibition.
A novel rhodopsin phosphodiesterase from the protist Salpingoeca rosetta (SrRhoPDE) was discovered in 2017. However, the previous two studies of 2017 claimed a very weak or absent light-regulation. Here I give strong evidence for light-regulation by studying the activity of SrRhoPDE, expressed in Xenopus laevis oocytes, in-vitro at different cGMP concentrations. Surprisingly, hydrolysis of cGMP shows a ~100-fold higher turnover than that of cAMP. Light can enhance substrate affinity by decreasing the Km value for cGMP from 80 μM to 13 μM, but increases the maximum turnover only by ~30%. In addition, two key single mutants, SrRhoPDE K296A or K296M, can abolish the light-activation effect by interrupting a covalent bond of Schiff base type to the chromophore retinal. I also demonstrate that SrRhoPDE shows cytosolic N- and C- termini, most likely via an 8-TM structure. In the future, SrRhoPDE can be a potentially useful optogenetic tool for light-regulation of cGMP concentration, possibly after further improvements by genetic engineering.
In 2006, 0.18 Mio pediatric nuclear medicine diagnostic exams were performed worldwide. However, for most of the radiopharmaceuticals used data on biokinetics and, as a consequence on dosimetry, are missing or have not been made publicly available. Therefore, most of the dosimetry assessments presented today for diagnostic agents in children and adolescents rely on the biokinetics data of adults. Even for one of the most common nuclear medicine exams for this patient group, renal scintigraphy with 99mTc-MAG3 for assessing renal function measured data on biokinetics is available only from a study performed on four children of different ages. In particular, renal scans are among the most frequent exams performed on infants and toddlers. Due to the young age, this patient group can be classified as a risk group with a higher probability of developing stochastic radiation effects compared to adults. As there are only limited data on biokinetics and dosimetry in this patient group, the aim of this study is to reassess the dosimetry and the associated radiation risk for a larger number of infants undergoing 99mTc-MAG3 renal scans based on a retrospective analysis of existing patient data.
Data were collected retrospectively from 34 patients younger than 20 months with normal (20 patients) and abnormal renal function (14 patients) undergoing 99mTc-MAG3 scans. The patient-specific organ activity was estimated based on a retrospective calibration which was performed based on a set of two 3D-printed infant kidneys (newborns: 8.6 ml; 1-year-old: 23.4 ml) filled with known activities. Both phantoms were scanned at different positions along the anteroposterior axis inside a water phantom, providing depth- and size-dependent attenuation correction factors for planar imaging. Time-activity curves were determined by drawing kidney, bladder, and whole body regions-of-interest for each patient, and subsequently applying the calibration factor for conversion of counts to activity. Patient-specific time-integrated activity coefficients were obtained by integrating the organ-specific time-activity curves. Absorbed and effective dose coefficients for each patient were assessed with OLINDA/EXM for the provided newborn and 1-year-old phantom. Based on absorbed dose values, the radiation risk estimation was performed individually for each of the 34 patients with the National Cancer Institute’s Radiation Risk Assessment Tool.
The patients’ organ-specific mean absorbed dose coefficients for the patients with normal renal function were 0.04±0.03 mGy/MBq for the kidneys and 0.27±0.24 mGy/MBq for the bladder. This resulted in a mean effective dose coefficient of 0.02±0.02 mSv/MBq. Based on the dosimetry results, the evaluation of the excess lifetime risk (ELR) for the development of radiation-induced cancer showed that the group of newborns has an ELR of 16.8 per 100,000 persons, which is higher in comparison with the 1-year-old group with an ELR of 14.7 per 100,000 persons. With regard to the 14 patients with abnormal renal function, the mean values for the organ absorbed dose coefficients for the patients were: 0.40±0.34 mGy/MBq for the kidneys and 0.46±0.37 mGy/MBq for the bladder. The corresponding effective dose coefficients (mSv/MBq) was: 0.05±0.02 mSv/MBq. The mean ELR (per 100,000 persons) for developing cancer from radiation exposure for patients with abnormal renal function was 29.2±18.7 per 100,000 persons.
As a result, the radiation-associated stochastic risk increases with the organ doses, taking age- and gender-specific influences into account. Overall, the lifetime radiation risk associated with the 99mTc-MAG3 scans is very low in comparison to the general population risk for developing cancer.
Furthermore, due to the increasing demand for PET-scans in children and adolescents with 68Ga-labelled peptides, in this work published data sets for those compounds were analyzed to derive recommendations for the administered activities in children and adolescents. The recommendation for the activities to be administered were based on the weight-independent effective dose model, proposed by the EANM Pediatric Dosage Card for application in pediatric nuclear medicine. The aim was to derive recommendations on administered activities for obtaining age-independent effective doses. Consequently, the corresponding weight-dependent effective dose coefficients were rescaled according to the formalism of the EANM dosage card, to determine the radiopharmaceutical class of 68Ga-labeled peptides (“multiples”), and to calculate the baseline activities based on the biokinetics of these compounds and an upper limit of the administered activity of 185 MBq for an adult. Analogous to 18F-fluoride, a minimum activity of 14 MBq is recommended. As a result, for those pediatric nuclear medicine applications involving 68Ga-labeled peptides, new values for the EANM dosage card were proposed and implemented based on the results derived in this work.
Overall, despite the low additional radiation-related cancer risk, all efforts should be undertaken to optimize administered activities in children and adolescents for obtaining sufficient diagnostic information with minimal associated radiation risk.
The evolutionary conserved Myb-MuvB (MMB) multiprotein complex is a transcriptional master regulator of mitotic gene expression. The MMB subunits B-MYB, FOXM1 as well as target genes of MMB are often overexpressed in different cancer types. Elevated expression of these genes correlates with an advanced tumor state and a poor prognosis for patients. Furthermore, it has been reported that pathways, which are involved in regulating the mitotic machinery are attractive for a potential treatment of cancers harbouring Ras mutations (Luo et al., 2009).
This suggest that the MMB complex could be required for tumorigenesis by mediating overactivity of mitotic genes and that the MMB could be a useful target for lung cancer treatment. However, although MMB has been characterized biochemically, the contribution of MMB to tumorigenesis is largely unknown in particular in vivo.
In this thesis, it was demonstrated that the MMB complex is required for lung tumorigenesis in vivo in a mouse model of non small cell lung cancer. Elevated levels of B-MYB, NUSAP1 or CENPF in advanced tumors as opposed to low levels of these proteins levels in grade 1 or 2 tumors support the possible contribution of MMB to lung tumorigenesis and the oncogenic potential of B-MYB.The tumor growth promoting function of B-MYB was illustrated by a lower fraction of KI-67 positive cells in vivo and a significantly high impairment in proliferation after loss of B-Myb in vitro. Defects in cytokinesis and an abnormal cell cycle profile after loss of B-Myb underscore the impact of B-MYB on proliferation of lung cancer cell lines. The incomplete recombination of B-Myb in murine lung tumors and in the tumor derived primary cell lines illustrates the selection pressure against the complete loss of B-Myb and further demonstrats that B-Myb is a tumor-essential gene. In the last part of this thesis, the contribution of MMB to the proliferation of human lung cancer cells was demonstrated by the RNAi-mediated depletion of B-Myb. Detection of elevated B-MYB levels in human adenocarcinoma and a reduced proliferation, cytokinesis defects and abnormal cell cycle profile after loss of B-MYB in human lung cancer cell lines underlines the potential of B-MYB to serve as a clinical marker.
Mammalian haloacid dehalogenase (HAD)-type phosphatases are a large and ubiquitous family of at least 40 human members. Many of them have important physiological functions, such as the regulation of intermediary metabolism and the modulation of enzyme activities, yet they are also linked to diseases such as cardiovascular or metabolic disorders and cancer.
Still, most of the mammalian HAD phosphatases remain functionally uncharacterized.
This thesis reveals novel cell biological and physiological functions of the phosphoglycolate phosphatase PGP, also referred to as AUM. To this end, PGP was functionally characterized by performing analyses using purified recombinant proteins to investigate potential protein substrates of PGP, cell biological studies using the spermatogonial cell line GC1, primary mouse lung endothelial cells and lymphocytes, and a range of biochemical techniques to characterize Pgp-deficient mouse embryos.
To characterize the cell biological functions of PGP, its role downstream of RTK- and integrin signaling in the regulation of cell migration was investigated. It was shown that PGP inactivation elevates integrin- and RTK-induced circular dorsal ruffle (CDR) formation, cell spreading and cell migration. Furthermore, PGP was identified as a negative regulator of directed lymphocyte migration upon integrin- and GPCR activation.
The underlying mechanisms were analyzed further. It was demonstrated that PGP regulates CDR formation and cell migration in a PLC- and PKC-dependent manner, and that Src family kinase activities are required for the observed cellular effects. Upon integrin- and RTK activation, phosphorylation levels of tyrosine residues 1068 and 1173 of the EGF receptor were elevated and PLCγ1 was hyper-activated in PGP-deficient cells. Additionally, PGP-inactivated lymphocytes displayed elevated PKC activity, and PKC-mediated cytoskeletal remodeling was accelerated upon loss of PGP activity. Untargeted lipidomic analyses revealed that the membrane lipid phosphatidylserine (PS) was highly upregulated in PGP-depleted cells.
These data are consistent with the hypothesis that the accumulation of PS in the plasma membrane leads to a pre-assembly of signaling molecules such as PLCγ1 or PKCs that couple the activation of integrins, EGF receptors and GPCRs to accelerated cytoskeletal remodeling.
Thus, this thesis shows that PGP can affect cell spreading and cell migration by acting as a PG-directed phosphatase.
To understand the physiological functions of PGP, conditionally PGP-inactivated mice were analyzed. Whole-body PGP inactivation led to an intrauterine growth defect with developmental delay after E8.5, resulting in a gradual deterioration and death of PgpDN/DN embryos between E9.5 and E11.5. However, embryonic lethality upon whole-body PGP inactivation was not caused by a primary defect of the (cardio-) vascular system. Rather, PGP inactivated embryos died during the intrauterine transition from hypoxic to normoxic conditions.
Therefore, the potential impact of oxygen on PGP-dependent cell proliferation was investigated. Analyses of mouse embryonic fibroblasts (MEFs) generated from E8.5 embryos and GC1 cells cultured under normoxic and hypoxic conditions revealed that normoxia (~20% O2) causes a proliferation defect in PGP-inactivated cells, which can be rescued under
hypoxic (~1% O2) conditions. Mechanistically, it was found that the activity of triosephosphate isomerase (TPI), an enzyme previously described to be inhibited by phosphoglycolate (PG) in vitro, was attenuated in PGP-inactivated cells and embryos. TPI constitutes a critical branch point between carbohydrate- and lipid metabolism because it catalyzes the isomerization of the glycolytic intermediates dihydroxyacetone phosphate (DHAP, a precursor of the glycerol backbone required for triglyceride biosynthesis) and glyceraldehyde 3’-phosphate (GADP).
Attenuation of TPI activity, likely explains the observed elevation of glycerol 3-phosphate levels and the increased TG biosynthesis (lipogenesis). Analyses of ATP levels and oxygen consumption rates (OCR) showed that mitochondrial respiration rates and ATP production were elevated in PGP-deficient cells in a lipolysis-dependent manner. However under hypoxic conditions (which corrected the impaired proliferation of PGP-inactivated cells), OCR and ATP production was indistinguishable between PGP-deficient and PGP-proficient cells. We therefore propose that the inhibition of TPI activity by PG accumulation due to loss of PGP activity shifts cellular bioenergetics from a pro-proliferative, glycolytic metabolism to a lipogenetic/lipolytic metabolism.
Taken together, PGP acts as a metabolic phosphatase involved in the regulation of cell migration, cell proliferation and cellular bioenergetics. This thesis constitutes the basis for further studies of the interfaces between these processes, and also suggests functions of PGP for glucose and lipid metabolism in the adult organism.
The culture of human induced pluripotent stem cells (hiPSCs) at large-scale becomes feasible with the aid of scalable suspension setups in continuously stirred tank reactors (CSTRs). Suspension cul- tures of hiPSCs are characterized by the self-aggregation of single cells into macroscopic cell aggre- gates that increase in size over time. The development of these free-floating aggregates is dependent on the culture vessel and thus represents a novel process parameter that is of particular interest for hiPSC suspension culture scaling. Further, aggregates surpassing a critical size are prone to spon- taneous differentiation or cell viability loss. In this regard, and, for the first time, a hiPSC-specific suspension culture unit was developed that utilizes in situ microscope imaging to monitor and to characterize hiPSC aggregation in one specific CSTR setup to a statistically significant degree while omitting the need for error-prone and time-intensive sampling. For this purpose, a small-scale CSTR system was designed and fabricated by fused deposition modeling (FDM) using an in-house 3D- printer. To provide a suitable cell culture environment for the CSTR system and in situ microscope, a custom-built incubator was constructed to accommodate all culture vessels and process control devices. Prior to manufacture, the CSTR design was characterized in silico for standard engineering parameters such as the specific power input, mixing time, and shear stress using computational fluid dynamics (CFD) simulations. The established computational model was successfully validated by comparing CFD-derived mixing time data to manual measurements. Proof for system functionality was provided in the context of long-term expansion (4 passages) of hiPSCs. Thereby, hiPSC aggregate size development was successfully tracked by in situ imaging of CSTR suspensions and subsequent automated image processing. Further, the suitability of the developed hiPSC culture unit was proven by demonstrating the preservation of CSTR-cultured hiPSC pluripotency on RNA level by qRT-PCR and PluriTest, and on protein level by flow cytometry.
All living organisms need timekeeping mechanisms to track and anticipate cyclic changes in their environment. The ability to prepare for and respond to daily and seasonal changes is endowed by circadian clocks. The systemic features and molecular mechanisms that drive circadian rhythmicity are highly conserved across kingdoms. Therefore, Drosophila melanogaster with its relatively small brain (ca. 135.000 neurons) and the outstanding genetic tools that are available, is a perfect model to investigate the properties and relevance of the circadian system in a complex, but yet comprehensible organism.
The last 50 years of chronobiological research in the fruit fly resulted in a deep understanding of the molecular machinery that drives circadian rhythmicity, and various histological studies revealed the neural substrate of the circadian system. However, a detailed neuroanatomical and physiological description on the single-cell level has still to be acquired. Thus, I employed a multicolor labeling approach to characterize the clock network of Drosophila melanogaster with single-cell resolution and additionally investigated the putative in- and output sites of selected neurons.
To further study the functional hierarchy within the clock network and to monitor the “ticking clock“ over the course of several circadian cycles, I established a method, which allows us to follow the accumulation and degradation of the core clock genes in living brain explants by the means of bioluminescence imaging of single-cells.
Studies on the role of platelet serotonin in platelet function, hemostasis, thrombosis and stroke
(2019)
Platelet activation and aggregation are important processes in hemostasis resulting in reduction of blood loss upon vessel wall injury. However, platelet activation can lead to thrombotic events causing myocardial infarction and stroke. A more detailed understanding of the regulation of platelet activation and the subsequent formation of thrombi is essential to prevent thrombosis and ischemic stroke. Cations, platelet surface receptors, cytoskeletal rearrangements, activation of the coagulation cas-cade and intracellular signaling molecules are important in platelet activation and thrombus formation. One such important molecule is serotonin (5 hydroxytryptamin, 5 HT), an indolamine platelet agonist, biochemically derived from tryptophan. 5 HT is secreted from the enterochromaffin cells into the gastrointestinal tract (GI) and blood. Blood borne 5 HT has been proposed to regulate hemostasis by acting as a vaso-constrictor and by triggering platelet signaling through 5 HT2A receptor. Although platelets do not synthetize 5 HT, they take it up from the blood and store it in their dense granules which are secreted upon platelet activation. To identify the molecu-lar composite of the 5 HT uptake system in platelets and elucidate the role of platelet released 5-HT in thrombosis and ischemic stroke, 5 HT transporter knock out mice (5Htt / ) were analyzed in different in vitro and in vivo assays and in a model of is-chemic stroke. In 5Htt / platelets, 5 HT uptake from the blood was completely abol-ished and agonist-induced Ca2+ influx through store operated Ca2+ entry (SOCE), integrin activation, degranulation and aggregation responses to glycoprotein (GP) VI and C type lectin-like receptor 2 (CLEC 2) were reduced. These observed in vitro defects in 5Htt / platelets could be normalized by the addition of exogenous 5 HT. Moreover, reduced 5 HT levels in the plasma, an increased bleeding time and the formation of unstable thrombi were observed ex vivo under flow and in vivo in the abdominal aorta and carotid artery of 5Htt / mice. Surprisingly, in the transient middle cerebral artery occlusion model (tMCAO) of ischemic stroke 5Htt / mice showed near-ly normal infarct volumes and a neurological outcome comparable to control mice. Although secreted platelet 5 HT does not appear to play a crucial role in the devel-opment of reperfusion injury after stroke, it is essential to amplify the second phase of platelet activation through SOCE and thus plays an important role in thrombus stabilization.
To further investigate the role of cations, granules and their contents and regulation of integrin activation in the process of thrombus formation, genetically modified mice were analyzed in the different in vivo thrombosis models. Whereas Tph1 / mice (lacking the enzyme responsible for the production of 5 HT in the periphery), Trpm7KI (point mu-tation in the kinase domain of Trpm7 channel, lacking kinase activity) and Unc13d / /Nbeal2 / mice (lacking α granules and the release machinery of dense granules) showed a delayed thrombus formation in vivo, MagT1y/ mice (lacking a specific Mg2+ transporter) displayed a pro thrombotic phenotype in vivo. Trpm7fl/fl Pf4Cre (lacking the non specific Mg2+ channel) and RIAM / mice (lacking a potential linker protein in integrin “inside out” signaling) showed no alterations in thrombus formation upon injury of the vessel wall.